FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W102938107> ?p ?o ?g. }

• W102938107 endingPage "1780" @default.
• W102938107 startingPage "1773" @default.
• W102938107 abstract "This phase I study evaluated the maximum tolerated dose, dose-limiting toxicity and recommended dose of docetaxel in combination with 5-fluorouracil (5-FU) in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy. 32 patients received docetaxel at 60, 75, 85 or 100 mg/m(2) by 1-h intravenous (i.v.) infusion, followed, after a 1-h interval, by 5-FU at 250, 350, 500 or 750 mg/m(2)/day by continuous infusion over 5 days every 3 weeks. Dose-limiting stomatitis defined the maximum tolerated dose at a docetaxel dose of 100 mg/m(2) with 5-FU 750 mg/m(2)/day. None of 5 patients treated at the previous dose level (docetaxel 85 mg/m(2) with 5-FU 750 mg/m(2)/day) had a dose-limiting toxicity in the first cycle, and this was, therefore, considered the recommended dose. The combination was generally well tolerated. Grade 4 neutropenia was common (29 patients; 91%), but no patient experienced febrile neutropenia of duration >3 days requiring i.v. antibiotics. An objective response was achieved by 18 patients overall (56%), and in 4 out of 5 patients treated with the determined recommended dose. No pharmacokinetic interaction between docetaxel and 5-fluorouracil was apparent. The activity of docetaxel 85 mg/m(2) with 5-fluorouracil 750 mg/m(2)/day will be explored more extensively in phase II studies of patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy." @default.
• W102938107 created "2016-06-24" @default.
• W102938107 creator A5024750557 @default.
• W102938107 creator A5026462289 @default.
• W102938107 creator A5037256369 @default.
• W102938107 creator A5056083434 @default.
• W102938107 creator A5056482680 @default.
• W102938107 creator A5072225627 @default.
• W102938107 creator A5075460094 @default.
• W102938107 creator A5081664619 @default.
• W102938107 date "2000-09-01" @default.
• W102938107 modified "2023-09-26" @default.
• W102938107 title "Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy" @default.
• W102938107 cites W1841504999 @default.
• W102938107 cites W1968785826 @default.
• W102938107 cites W1978174861 @default.
• W102938107 cites W1978228326 @default.
• W102938107 cites W2000389237 @default.
• W102938107 cites W2015654855 @default.
• W102938107 cites W2018636040 @default.
• W102938107 cites W2018669337 @default.
• W102938107 cites W2049742577 @default.
• W102938107 cites W2050088084 @default.
• W102938107 cites W2051110408 @default.
• W102938107 cites W2062484718 @default.
• W102938107 cites W2126871433 @default.
• W102938107 cites W2271076065 @default.
• W102938107 cites W2271965271 @default.
• W102938107 cites W29484456 @default.
• W102938107 cites W4237434210 @default.
• W102938107 cites W4362046093 @default.
• W102938107 cites W2015191990 @default.
• W102938107 doi "https://doi.org/10.1016/s0959-8049(00)00176-3" @default.
• W102938107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10974625" @default.
• W102938107 hasPublicationYear "2000" @default.
• W102938107 type Work @default.
• W102938107 sameAs 102938107 @default.
• W102938107 citedByCount "15" @default.
• W102938107 countsByYear W1029381072020 @default.
• W102938107 crossrefType "journal-article" @default.
• W102938107 hasAuthorship W102938107A5024750557 @default.
• W102938107 hasAuthorship W102938107A5026462289 @default.
• W102938107 hasAuthorship W102938107A5037256369 @default.
• W102938107 hasAuthorship W102938107A5056083434 @default.
• W102938107 hasAuthorship W102938107A5056482680 @default.
• W102938107 hasAuthorship W102938107A5072225627 @default.
• W102938107 hasAuthorship W102938107A5075460094 @default.
• W102938107 hasAuthorship W102938107A5081664619 @default.
• W102938107 hasConcept C121608353 @default.
• W102938107 hasConcept C126322002 @default.
• W102938107 hasConcept C126894567 @default.
• W102938107 hasConcept C143998085 @default.
• W102938107 hasConcept C2775930923 @default.
• W102938107 hasConcept C2776694085 @default.
• W102938107 hasConcept C2776802502 @default.
• W102938107 hasConcept C2777063308 @default.
• W102938107 hasConcept C2778850193 @default.
• W102938107 hasConcept C2779051857 @default.
• W102938107 hasConcept C2780456651 @default.
• W102938107 hasConcept C2781190966 @default.
• W102938107 hasConcept C29730261 @default.
• W102938107 hasConcept C530470458 @default.
• W102938107 hasConcept C71924100 @default.
• W102938107 hasConcept C90924648 @default.
• W102938107 hasConceptScore W102938107C121608353 @default.
• W102938107 hasConceptScore W102938107C126322002 @default.
• W102938107 hasConceptScore W102938107C126894567 @default.
• W102938107 hasConceptScore W102938107C143998085 @default.
• W102938107 hasConceptScore W102938107C2775930923 @default.
• W102938107 hasConceptScore W102938107C2776694085 @default.
• W102938107 hasConceptScore W102938107C2776802502 @default.
• W102938107 hasConceptScore W102938107C2777063308 @default.
• W102938107 hasConceptScore W102938107C2778850193 @default.
• W102938107 hasConceptScore W102938107C2779051857 @default.
• W102938107 hasConceptScore W102938107C2780456651 @default.
• W102938107 hasConceptScore W102938107C2781190966 @default.
• W102938107 hasConceptScore W102938107C29730261 @default.
• W102938107 hasConceptScore W102938107C530470458 @default.
• W102938107 hasConceptScore W102938107C71924100 @default.
• W102938107 hasConceptScore W102938107C90924648 @default.
• W102938107 hasIssue "14" @default.
• W102938107 hasLocation W1029381071 @default.
• W102938107 hasLocation W1029381072 @default.
• W102938107 hasOpenAccess W102938107 @default.
• W102938107 hasPrimaryLocation W1029381071 @default.
• W102938107 hasRelatedWork W102938107 @default.
• W102938107 hasRelatedWork W1973241390 @default.
• W102938107 hasRelatedWork W2004842027 @default.
• W102938107 hasRelatedWork W2024961744 @default.
• W102938107 hasRelatedWork W2029752720 @default.
• W102938107 hasRelatedWork W2096955328 @default.
• W102938107 hasRelatedWork W2103792825 @default.
• W102938107 hasRelatedWork W2111487955 @default.
• W102938107 hasRelatedWork W2184025371 @default.
• W102938107 hasRelatedWork W2327499413 @default.
• W102938107 hasVolume "36" @default.
• W102938107 isParatext "false" @default.
• W102938107 isRetracted "false" @default.

• next